Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures.

Diabetes Technol Ther · 2017 · PMC5444481 · PMID 28467113

Europe PMC DOI

hedged sentence

0.0678

closest p · 1.4× alpha

0.0678

boldest claim

The sentences

a nonsignificant trendP = 0.0678so close (0.05 < p ≤ 0.1)

In the HR cohort, patients treated with Gla-300 showed a nonsignificant trend toward lower nocturnal hypoglycemia compared with those treated with Gla-100 (EDITION 2, 25.3% vs. 38.0%, P = 0.0678; EDITION 3, 24.2% vs. 32.7%, P = 0.1903) ( Table 3 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.